Literature DB >> 6114483

Effects of histamine H1- and H2-receptor antagonists on dopamine, noradrenaline and serotonin systems in rat brain.

J Z Nowak.   

Abstract

The action of histamine H1-receptor antagonists: chloropyramine (CIPYR), diphenhydramine (DPHA) and mepyramine (MEP), and histamine H2-receptor antagonist: burimamide (BUR), metiamide (MET) and cimetidine (CIM) and their methylated analogues methylburimamide (MeBUR) and thiaburimamide (ThBUR) on brain monoamines dopamine (DA), noradrenaline (NA) and serotonin (5HT) in the rat was investigated. H1-receptor antagonists CIPYR and DPHA did not significantly influence both DA disappearance after kappa-methyl-p-tyrosine and DOPAC levels in the rat striatum. DPHA had no significant effect on the striatal DA content while CIPYR decreased it. All of the tested H1-receptor antagonists increased both NA and 5HT levels and decreased 5-HIAA concentrations in the hypothalamus and the striatum. Large doses of H2-receptor antagonists (50-259 micrograms ivt) decreased hypothalamic NA content. One nanogram of BUR, MET and ThBUR in NA levels, while such low doses of MeBUR nd CIM did not affect the amine content in the rat hypothalamus, neither acute nor chronic treatment with CIN ip significantly influenced NA,DA and 5HT levels in the brain.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6114483

Source DB:  PubMed          Journal:  Pol J Pharmacol Pharm        ISSN: 0301-0244


  2 in total

1.  Effect of a combination of duloxetine with hydroxyzine on experimental models of anxiety in mice.

Authors:  Sonam Patel; Pravin Popatrao Kale; Veeranjaneyulu Addepalli; Amrita Sarkar; Jay Savai
Journal:  Indian J Pharmacol       Date:  2015 Mar-Apr       Impact factor: 1.200

2.  Activation of carbonic anhydrase isoforms involved in modulation of emotional memory and cognitive disorders with histamine agonists, antagonists and derivatives.

Authors:  Gustavo Provensi; Alessio Nocentini; Maria Beatrice Passani; Patrizio Blandina; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.